Hepatocellular carcinoma: is surveillance cost effective?


Autoria(s): Bruix Tudó, Jordi; Llovet i Bayer, Josep Maria
Contribuinte(s)

Universitat de Barcelona

Data(s)

26/07/2011

Identificador

http://hdl.handle.net/2445/18668

Idioma(s)

eng

Publicador

BMJ Group

Direitos

(c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2001

Palavras-Chave #Càncer de fetge #Medicina preventiva #Salut pública #Liver cancer #Preventive medicine #Public health
Tipo

info:eu-repo/semantics/article